Rhumbline Advisers Prime Medicine, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 97,972 shares of PRME stock, worth $631,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,972
Previous 81,900
19.62%
Holding current value
$631,919
Previous $162,000
48.77%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PRME
# of Institutions
130Shares Held
55.9MCall Options Held
182KPut Options Held
211K-
Alphabet Inc. Mountain View, CA15.1MShares$97.2 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.48MShares$41.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$23.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.32MShares$15 Million0.05% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $617M